Big Pharma

Hypertension poses major health risk for patients in middle income countries Many people diagnosed with hypertension in four of the world’s biggest middle-income countries stop treatment and most of these patients lose control of blood pressure – potentially leading to heart problems and death, a new study reveals.   Analysing patient data from China, Indonesia, Mexico, and South Africa, experts found that policies solely aimed at improving diagnosis or initiating treatment may not lead to long-term hypertension control improvements in these and similar countries.   Researchers investigating how people with hypertension move through care over time looked at adults aged...

P-Cure Prepares to Meet Market Demand by Setting Up the Largest Production Facility of Proton Therapy Systems in the World P-Cure Ltd., the provider of the most compact 360o Gantry-less Adaptive Proton Therapy System that can be installed in existing radiotherapy vaults, announced the establishment of a new production facility in Weifang, Shandong Province, China.   P-Cure 360 Degree Gantry-less Adaptive Proton Therapy System “P-Cure is the only provider of proton therapy that can effectively install the latest cancer fighting technology within the vault instead of new linac (x-ray) equipment,” says P-Cure CEO Michael Marash. TEL AVIV, Israel (PRWEB)  P-Cure...

Introducing rebless™ Robotic Therapy at Brooks Rehabilitation Brooks Rehab builds on its mission to offer a personalized experience to help empower you throughout your recovery by aligning closely with H Robotics. AUSTIN, Texas (PRWEB) June 07, 2022 Recently, H Robotics traveled to Central Florida to work together with clinicians at Brooks Rehabilitation, providing rebless™ training and support for patients who are affected by stroke, traumatic injury, or who are recovering from orthopedic surgery. This new relationship plays an important role in H Robotic’s mission to restore movement and create a better quality of life with data-driven technology for patients. “We...

Catalent Expands Primary Packaging Capabilities at its Clinical Supply Facility in Shiga, Japan Catalent Facility in Shiga, Japan Shiga is a key hub within our Asia-Pacific clinical supply services network, and with these new capabilities, which are now fully operational, we will offer a comprehensive range of services, which are customizable to customers’ specific needs. SOMERSET, N.J. (PRWEB) June 30, 2022 Catalent, the global leader in enabling biopharma, cell, gene and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced that it has expanded its primary packaging capabilities at its clinical...

Third generation of patents for the Bactiguard technology will be granted Bactiguard has been informed that the European Patent Office (EPO) intends to grant a European patent for Bactiguard’s infection prevention technology. The new patent, which is the third generation, will provide extensive worldwide protection for the Bactiguard technology until 2039. -          We are very pleased that the EPO has confirmed that the new generation of patents will be granted. This will further strengthen and extend the worldwide protection for the versatile Bactiguard technology and make it even more attractive for existing and new license partners, says Anders Göransson, CEO....